Trial Profile
A Phase I Trial to Evaluate Acute and Late Toxicities of Concurrent Treatment With Everolimus (RAD001) and Radio-Hormonotherapy in High-risk Prostate Cancer.(RHOMUS)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Bicalutamide; Leuprorelin
- Indications Prostate cancer
- Focus Adverse reactions
- 04 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Jul 2009 New trial record